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The government is acutely aware of the importance
of keeping the public on board. Without the trust and
confidence of the public, introducing genetics into
mainstream NHS activities could be a high risk
enterprise. Ministerial fingers were burned by the
fiasco surrounding the introduction of genetically
modified foods and crops, and the Department of
Health is determined that this must not happen with
the introduction of genetic medicine.
Striking the balance between unrealistic expecta-
tions and unfounded fears will be vital. Genetics is not
going to hit the NHS like a tidal wave. Rather it will be
like rising damp that gradually permeates almost every
aspect of health care. To sustain the public’s
confidence, the white paper proposes a strengthening
of regulations. A new law will make it a criminal
offence to test a person’s DNA without their consent.
The police and courts will have special privileges in this
area. The government will think about the best way of
preventing unfair genetic discrimination, especially in
areas such as insurance and employment, but no
specific legislation is proposed.
One controversial suggestion is that babies could
be screened at birth to produce “a comprehensive map
of their key genetic markers, or even their entire
genome.” Leaving aside the thorny issue of how a new-
born can consent to genetic testing, one wonders why
a DNA sample taken at birth is any more useful than
one taken later in life. The Human Genetics Commis-
sion (whose work provided many of the ideas in the
white paper)8 and the National Screening Committee
have been asked to consider this proposal and report
by the end of 2004.
What will the white paper mean for ordinary mem-
bers of the British public? For individuals and families
affected by conditions caused by chromosomal abnor-
malities and mutations in single genes, there will be
more genetic counsellors, more laboratory staff and
equipment, and more and faster genetic tests. Within
three years, NHS laboratories should be able to
provide a 21st century service: prenatal tests will be
available in days, and complex searches for mutations
will take eight weeks (currently they sometimes take
many months).
What about the 95% of people who do not have
diseases caused by single genes? The white paper flirts
with the prospect of tests that will predict susceptibility
to common diseases, such as cancer and heart disease,
but there are no promises of when, if ever, these will
become a reality. Pharmacogenetics—the ability to use
genetic characteristics to choose appropriate drugs for
patients—is said to be coming soon. The white paper
does not mention how general practitioners will fit a
genetic test into a consultation lasting seven minutes. A
few case histories of patients who might benefit from
the new genetics are scattered through the white paper,
but for those of us who do not metabolise warfarin
unusually slowly and do not have maturity onset
diabetes of the young, the practical benefits seem a
long way down the road.
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Water, sanitation, and hygiene at Kyoto
Handwashing and sanitation need to be marketed as if they were consumer products
When John Snow removed the handle of theBroad Street pump in London’s Soho in1854, he took his place in history as the dis-
coverer of the mode of transmission of cholera and the
father of epidemiology. But were Snow alive today he
would be horrified to hear that we still only apply the
benefits of his insights to the richest half of humanity
and that, as a result, over 2 million children still die
each year from diarrhoeal diseases.1 He would also be
amazed to find that our understanding of diarrhoeal
diseases and how to prevent them has advanced very
little in the century and a half since he wrote his
famous paper.2 One of the greatest failures of the last
century has undoubtedly been the failure to lay the
foundation stones of public health in the developing
world—hygiene, sanitation, and water supply. Did the
Third World Water Forum, held in Kyoto in March
2003, offer any new hope for the billions still “waiting
for the toilet?”
Kyoto was important because it marked a turning
point in thinking about hygiene, sanitation, and water.
Of the three, water has always had the lion’s share of
both the attention and the resources. However,
politicians are finally coming to realise that hygiene
and sanitation are at least as important. The table sum-
marises the results of reviews of the impact of
improved water, sanitation, and hygiene on diarrhoeal
diseases. These results imply that improving the quality
of water supplies cuts the risk of diarrhoea by only
about 16% (although it has other benefits) and making
water more available reduces the risk by 20%. Installing
adequate facilities to dispose of bodily excretions and
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promoting hygiene, however, are twice as effective. A
recent systematic review of the impact of washing
hands with soap shows that this specific practice may
be almost three times as effective as improving water
quality, cutting the risk of diarrhoea by 47%.
At Kyoto ministers accepted that they should no
longer concentrate on water alone but should also tackle
hygiene and toilets. They declared that governments
should develop strategies to halve the proportion of the
world’s population without sanitation by 2015 and to
focus on basic hygiene, including hand washing.
International aid to the tune of $5bn (£3bn; €4bn) a year
is available to help, and at Kyoto, the World Water Sup-
ply and Sanitation Collaborative Council called for this
sum to be doubled. Even with current levels of funding
much can be achieved, provided governments do make
sanitation and hygiene a priority.
However, because research into the diarrhoeal dis-
eases has been neglected for so long,many basic pieces
of knowledge about these issues are missing.We still do
not know the relative importance of human and
animal faeces in disease transmission, nor do we know
whether fingers, food, flies, or fomites are the most
important vectors of infection.6 We do not know the
best strategies for preventing viral diarrhoeas, and we
do not even know what agents are causing diarrhoea in
over half of cases.7 Most worryingly of all, we still do not
know which strategies are most effective in encourag-
ing people to install toilets and to adopt new hygiene
behaviours, although we have some ideas.
One promising strategy is to market sanitation and
handwashing as if they were consumer products like
cars or shampoo. Consumers see the building of a toilet
as a home improvement not as a health intervention.8
Equally they use soap to make hands look, feel, and
smell good, not to prevent sickness.9 Public money could
be spent on marketing hygiene and toilets, thus generat-
ing demand that can then be met by the private sector.
The private sector also knows how to generate
behaviour change through marketing. If consumer
demand for hygiene and toilets can be stimulated with
the help of the private sector, public funds can be liber-
ated to support public infrastructure and to help the
very poorest who cannot afford to adopt new technolo-
gies. This approach is being tested in six countries,
where public-private partnerships between soap compa-
nies, governments, and agencies such as theWorld Bank
aim to increase rates of handwashing with soap
massively (www.globalhandwashing.org).
Research is needed on all fronts in hygiene, sanita-
tion, and prevention of diarrhoea, and needs to be
done where the diarrhoea is. Politicians at Kyoto com-
mitted themselves to the local ownership of solutions
but did not consider how public health and
engineering departments in universities in developing
countries can get the resources they need, and to find
solutions directed at needs in their own countries.
Hygiene, sanitation, and water for all still remain
among the grand challenges for public health in the
21st century. The Third World Water Forum was a nec-
essary, but far from sufficient, step along the way
towards completing John Snow’s unfinished agenda.
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Managing agitation and aggression after head injury
Minimum use of drugs and early care in rehabilitation units are recommended
Too many patients recovering from a headinjury on medical and surgical wards across theUnited Kingdom are being given too much
haloperidol. This is a view voiced by members of the
UK Brain Injury Psychiatrists group, who are aware
that drugs to treat mental disorders are often given to
patients after head injury,1 though these patients are
particularly vulnerable to their side effects. For
example, haloperidol, is usually given to manage agita-
tion, can hinder recovery, and its side effects include
motor restlessness (akithisia) and increased confusion.2
There is a danger of the treatment chasing its own tail.
Although haloperidol may be quite appropriate for
the management of acute agitation or aggression if the
problem persists for more than one or two days, then “as
required” drugs should be stopped. A review of the
patient, if possible with the help of a liaison psychiatrist,3
will be needed before alternative treatment is started.
It is usual to distinguish agitation, defined as
disturbed behaviour as a result of overactivity, from
Effectiveness of specific interventions against risk of diarrhoeal
disease
Intervention Reduction in diarrhoea risk (%)
Improved water quality3 16
Improved water quantity3 20
Sanitation3 36
Hygiene education4 35
Handwashing with soap5 47
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